These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 19038965)

  • 41. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy of systemic morphine suggests a fundamental difference in the mechanisms that generate bone cancer vs inflammatory pain.
    Luger NM; Sabino MAC; Schwei MJ; Mach DB; Pomonis JD; Keyser CP; Rathbun M; Clohisy DR; Honore P; Yaksh TL; Mantyh PW
    Pain; 2002 Oct; 99(3):397-406. PubMed ID: 12406514
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Additive antinociceptive effects of the selective Nav1.8 blocker A-803467 and selective TRPV1 antagonists in rat inflammatory and neuropathic pain models.
    Joshi SK; Honore P; Hernandez G; Schmidt R; Gomtsyan A; Scanio M; Kort M; Jarvis MF
    J Pain; 2009 Mar; 10(3):306-15. PubMed ID: 19070548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effects of an intrathecal TRPV1 antagonist, SB366791, on morphine-induced itch, body temperature, and antinociception in mice.
    Sakakibara S; Imamachi N; Sakakihara M; Katsube Y; Hattori M; Saito Y
    J Pain Res; 2019; 12():2629-2636. PubMed ID: 31695478
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analgesic effects of capsazepine and resiniferatoxin on bone cancer pain in mice.
    Menéndez L; Juárez L; García E; García-Suárez O; Hidalgo A; Baamonde A
    Neurosci Lett; 2006 Jan; 393(1):70-3. PubMed ID: 16243435
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intravenous ketamine infusion as an adjuvant to morphine in a 2-year-old with severe cancer pain from metastatic neuroblastoma.
    Tsui BC; Davies D; Desai S; Malherbe S
    J Pediatr Hematol Oncol; 2004 Oct; 26(10):678-80. PubMed ID: 15454842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Differential involvement of TRPV1 receptors at the central and peripheral nerves in CFA-induced mechanical and thermal hyperalgesia.
    Kanai Y; Hara T; Imai A; Sakakibara A
    J Pharm Pharmacol; 2007 May; 59(5):733-8. PubMed ID: 17524240
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TRPV1 modulates morphine self-administration via activation of the CaMKII-CREB pathway in the nucleus accumbens.
    Ma SX; Kim HC; Lee SY; Jang CG
    Neurochem Int; 2018 Dec; 121():1-7. PubMed ID: 30292787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of acute morphine-induced analgesia measured by a thermal test in bone cancer-bearing mice.
    González-Rodríguez S; Llames S; Hidalgo A; Baamonde A; Menéndez L
    Fundam Clin Pharmacol; 2012 Jun; 26(3):363-72. PubMed ID: 21306432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels.
    Micale V; Cristino L; Tamburella A; Petrosino S; Leggio GM; Drago F; Di Marzo V
    Neuropsychopharmacology; 2009 Feb; 34(3):593-606. PubMed ID: 18580871
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antagonists to TRPV1, ASICs and P2X have a potential role to prevent the triggering of regional bone metabolic disorder and pain-like behavior in tail-suspended mice.
    Hanaka M; Iba K; Dohke T; Kanaya K; Okazaki S; Yamashita T
    Bone; 2018 May; 110():284-294. PubMed ID: 29452264
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management.
    Mercadante S; Porzio G; Ferrera P; Fulfaro F; Aielli F; Verna L; Villari P; Ficorella C; Gebbia V; Riina S; Casuccio A; Mangione S
    Eur J Pain; 2008 Nov; 12(8):1040-6. PubMed ID: 18353696
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Targeting pain-depressed behaviors in preclinical assays of pain and analgesia: drug effects on acetic acid-depressed locomotor activity in ICR mice.
    Stevenson GW; Cormier J; Mercer H; Adams C; Dunbar C; Negus SS; Bilsky EJ
    Life Sci; 2009 Aug; 85(7-8):309-15. PubMed ID: 19559034
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Intrathecal administration of the cannabinoid 2 receptor agonist JWH015 can attenuate cancer pain and decrease mRNA expression of the 2B subunit of N-methyl-D-aspartic acid.
    Gu X; Mei F; Liu Y; Zhang R; Zhang J; Ma Z
    Anesth Analg; 2011 Aug; 113(2):405-11. PubMed ID: 21519057
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Morphine, oxycodone, and fentanyl exhibit different analgesic profiles in mouse pain models.
    Minami K; Hasegawa M; Ito H; Nakamura A; Tomii T; Matsumoto M; Orita S; Matsushima S; Miyoshi T; Masuno K; Torii M; Koike K; Shimada S; Kanemasa T; Kihara T; Narita M; Suzuki T; Kato A
    J Pharmacol Sci; 2009 Sep; 111(1):60-72. PubMed ID: 19729873
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of the TRPV1 endogenous agonist N-Oleoyldopamine in modulation of nociceptive signaling at the spinal cord level.
    Spicarova D; Palecek J
    J Neurophysiol; 2009 Jul; 102(1):234-43. PubMed ID: 19369364
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological evaluation of morphine and non-opioid analgesic adjuvants in a mouse model of skin cancer pain.
    Andoh T; Sugiyama K; Fujita M; Iida Y; Nojima H; Saiki I; Kuraishi Y
    Biol Pharm Bull; 2008 Mar; 31(3):520-2. PubMed ID: 18310922
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [NMDA receptor and NOS in morphine tolerance in mice with bone cancer].
    Yan X; Huang X; Huang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 May; 35(5):458-63. PubMed ID: 20543469
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effects of TRPV1 inhibition against sevoflurane-induced cell death.
    Liu Y; Yang H; Sun C; Wang Z; Liu Z
    Neurosci Lett; 2019 Aug; 707():134270. PubMed ID: 31102705
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphine treatment accelerates sarcoma-induced bone pain, bone loss, and spontaneous fracture in a murine model of bone cancer.
    King T; Vardanyan A; Majuta L; Melemedjian O; Nagle R; Cress AE; Vanderah TW; Lai J; Porreca F
    Pain; 2007 Nov; 132(1-2):154-68. PubMed ID: 17706870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.